Café

© 2026 Longbridge｜Terms of Service Privacy Policy

ACROBIOSYSTEMS

301080

76.557.21% ( -5.95 )

Delay Closed: Aug 31, 15:00:00

OverviewOverview NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

ACROBIOSYSTEMS (301080)

Acrobiosystems Co.,Ltd. engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and bio...

Open: 80.00
High: 80.03
Low: 72.79
Prev. Close: 82.50
Volume: 141.58K
Turnover: 1.07B
Avg Price: 75.56
Bid/Ask Ratio: --
Amplitude: 8.78%
52wk High: 102.79
Volume Ratio: 1.64
Turnover Ratio: 8.44%

52wk Low: 35.27
Float Mkt Cap: 12.84B
Market Cap^CNY: 12.84B
P/E^TTM: 71.26
P/E^Dynamic: 65.25
P/E^Static: --
EPS^TTM: 1.07
EPS^Dynamic: 1.17
EPS^Static: --
BVPS: 15.90
P/B: 4.81
Circulating Supply: 167.68M
Dividend Yield^TTM: 0.78%
Dividend^TTM: 0.60
Shares: 167.68M
Min lot size: 100
Currency: CNY

ACROBIOSYSTEMS Analyst Rating

Forecast & Rating

Jul 31, 2026

Price forecast

¥72.71-5.02%

Forecast & RatingStrong buy

4analysts

Strong buy75.00%
Buy25.00%
Hold0.00%
Sell0.00%
Strong sell0.00%

Strong buy: 3
Buy: 1
Hold: 0
Sell: 0
Strong sell: 0

News

Unusual Whales · Aug 26 at 07:45 PM
Nature Biotechnology | Aureka Wins the Global Blinded AI Antibody Benchmark: AI Design Surpasses the Best Experimental Result
prnewswire · Jul 14 at 11:00 AM
12:00 ETACROBiosystems Obtains PMDA Material Suitability Confirmation for GMP-grade IL-15, Ensuring Reliable Quality and Strengthening the Biopharmaceutical Approval Process
prnewswire · May 12 at 02:05 AM
03:04 ETACROBiosystems Innovation Day Lands in Zurich: Top Minds Unite to Explore Biotech Frontiers